Recent studies (Sheedy et al., 2013; Dai et al., 2017) have demonstrated that CD36 triggers the NLRP3 inflammasome in atherosclerosis, while inhibition of CD36 suppresses NLRP3 inflammasome activation (Kang et al., 2016). This evidence concerns the gene CD36 and atherosclerosis.